EsoBiotec Doses First Patient in Investigator Initiated Trial of In Vivo BCMA CAR-T Candidate ESO-T01 for Multiple Myeloma
Initial clinical observations suggest high level of T cells reprogramming and CAR-T expansion at the starting dose without lymphodepletion At 28 ...
WuXi AppTec deal eases pressure from Congress on Penn and CHOP biotech
WuXi AppTec, the Shanghai-based biotech giant, has sold its South Philly-based WuXi Advanced Therapies contract manufacturing ...
presseagentur.com1d
QNX, Vector and TTTech Auto Join Forces to Develop Foundational Vehicle Software Platform to Turbocharge Auto Innovation
CES, LAS VEGAS, January 7, 2025 – QNX, a division of BlackBerry Limited (NYSE: BB; TSX:BB), Vector and TTTech Auto today ...
TMCnet1d
Locus Robotics Achieves CE Certification for High-Payload Vector Robot, Enabling New Possibilities in Flexible Warehouse Automation
With Locus Vector's CE certification, Locus Robotics continues to advance flexible automation, meeting the growing demand for ...
TMCnet2d
Veracode Acquires Phylum, Inc. Technology to Transform Software Supply Chain Security
Veracode, a global leader in application risk management, today announced it has acquired certain assets of Phylum, Inc., ...
News Medical2d
Setting new benchmarks in biopharmaceutical decontamination
Microbial neutralization must constantly achieve a six-log reduction threshold of Geobacillus stearothermophilus and comply ...
realestateasia2d
India’s data centre capacity to hit 3,250 MW IT by 2030
According to a recent Savills report, data centres in India are primarily concentrated in Mumbai, Chennai, Bengaluru, Hyderabad, and Delhi-NCR due to their conn ...
Oxford Biomedica Announces Total Voting Rights for 2024
Oxford Biomedica has announced its total voting rights as of 31 December 2024, amounting to 105,961,906 ordinary shares. This figure is significant for shareholders to calculate their interests under ...